Načítá se...
Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study
BACKGROUND: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrospective study, we aimed to assess the TBZ effectiveness and adverse events (AEs) in Huntington disease (HD), vascular chorea, tics, dystonia, tardive oromandibular (OM) dyskinesia and other tardive syn...
Uloženo v:
| Vydáno v: | Ther Adv Neurol Disord |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367646/ https://ncbi.nlm.nih.gov/pubmed/28382107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616677004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|